⌘K

Login Start Free

Home/Filings/4/0001193125-25-209353

4//SEC Filing

Kulkarni Samarth 4

Accession 0001193125-25-209353

CIK 0001674416other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:42 PM ET

Size

5.3 KB

Accession

0001193125-25-209353

Insider Transaction Report

Form 4

Period: 2025-09-17

CRISPR Therapeutics AGCRSP

Kulkarni Samarth

DirectorChief Executive Officer

Transactions

Gift
Common Shares
2025-09-17−6,000→ 201,004 total

Holdings

Common Shares
(indirect: The Kulkarni 2023 GRAT)
85,622

Footnotes (1)

[F1]The reporting person made a charitable contribution of common shares to a donor advised fund.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother

Related Parties

1

filerCIK 0001682019

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 5:42 PM ET
Size: 5.3 KB

View on SEC.gov